Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AMARANTUS BIOSCIENCE, INC. | 333,333 | reported | 09 Apr 2015 | tx 2+333,333 |
| TITAN PHARMACEUTICALS INC | 320,580 | reported | 21 Oct 2008 | tx 17+578,000 |
| BIONOVO INC | 30,000 | reported | 17 Jan 2012 | tx 1+30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Apr 2015 | PURCHASE | AMARANTUS BIOSCIENCE, INC. | 200,000 | 0.05 USD | |
| 19 Nov 2014 | PURCHASE | AMARANTUS BIOSCIENCE, INC. | 133,333 | 0.08 USD | first after silence |
| 17 Jan 2012 | GRANT_AWARD | BIONOVO INC | 30,000 | 0.00 USD | deriv |
| 21 Oct 2008 | GRANT_AWARD | TITAN PHARMACEUTICALS INC | 200,000 | 0.00 USD | |
| 04 Jan 2008 | PURCHASE | TITAN PHARMACEUTICALS INC | 3,950 | 1.61 USD | |
| 03 Jan 2008 | PURCHASE | TITAN PHARMACEUTICALS INC | 5,050 | 1.61 USD | |
| 02 Jan 2008 | GRANT_AWARD | TITAN PHARMACEUTICALS INC | 80,000 | 0.00 USD | deriv |
| 27 Apr 2007 | PURCHASE | TITAN PHARMACEUTICALS INC | 15,500 | 2.14 USD | |
| 20 Mar 2007 | PURCHASE | TITAN PHARMACEUTICALS INC | 400 | 2.29 USD | |
| 20 Mar 2007 | PURCHASE | TITAN PHARMACEUTICALS INC | 4,000 | 2.34 USD | |
| 20 Mar 2007 | PURCHASE | TITAN PHARMACEUTICALS INC | 18,400 | 2.40 USD | |
| 20 Mar 2007 | PURCHASE | TITAN PHARMACEUTICALS INC | 100 | 2.30 USD | anomaly |
| 20 Mar 2007 | PURCHASE | TITAN PHARMACEUTICALS INC | 1,000 | 2.32 USD | |
| 20 Mar 2007 | PURCHASE | TITAN PHARMACEUTICALS INC | 2,100 | 2.31 USD | |
| 03 Jan 2007 | GRANT_AWARD | TITAN PHARMACEUTICALS INC | 55,000 | 0.00 USD | deriv |
| 18 Sept 2006 | GRANT_AWARD | TITAN PHARMACEUTICALS INC | 45,000 | 0.00 USD | deriv |
| 03 Jan 2006 | GRANT_AWARD | TITAN PHARMACEUTICALS INC | 22,500 | 0.00 USD | deriv |
| 03 Jan 2006 | GRANT_AWARD | TITAN PHARMACEUTICALS INC | 45,000 | 0.00 USD | deriv |
| 09 Feb 2004 | GRANT_AWARD | TITAN PHARMACEUTICALS INC | 35,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 19 Nov 2014.